Apheresis Market worth 2.5 Billion USD by 2020


Posted July 1, 2016 by mmvaidya01

The global apheresis market is estimated to reach USD 2.5 Billion by 2020, growing at a CAGR of 11.2% during the forecast period (2015 to 2020).

 
Browse 139 tables and 45 figures spread through 195 Pages and in-depth TOC on "Apheresis Market"
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
Early buyers will receive 10% customization on this report.

This market is mainly driven by the increasing severity of blood shortage and growing concerns regarding blood safety, rapid growth in aging population, increasing number of surgical procedures and emergency treatment cases in hospitals, and increasing demand for source plasma from biopharmaceutical companies, worldwide. Extending reach of therapeutic apheresis in the global market and the application of therapeutic apheresis for pediatric treatment are expected to offer significant growth opportunities for the market in the coming years.

However, factors such as high cost of apheresis procedures, lack of awareness about the apheresis process, and challenges in donor recruitment are restraining the growth of the apheresis market.

Get PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=950

In this report, the apheresis market is segmented on the basis of product, procedure, technology, application, and region. The research report discusses the key market drivers, restraints, opportunities, and challenges in the global apheresis market and its submarkets.

On the basis of product, the market is segmented into devices and disposables. In 2014, the disposables segment accounted for the largest share­ 85.1% of the global market, and this segment is poised to grow at a CAGR of 11.6% during the forecast period. Growth in this market is attributed to the increasing demand for disposables with the increasing number of therapeutic apheresis procedures, and increasing trend towards apheresis blood collections.

Get The Sample Copy Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=950

On the basis of application, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share 46.5% of the global apheresis market in 2014. The large share of this segment is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies.

In this report, the global apheresis market is studied at regional and country levels. In 2014, North America commanded the largest share of the apheresis market, and this region is poised to continue to dominate the market during the forecast period. However, the Asia-Pacific region is expected to be the fastest-growing regional market in the coming years. Growth in this region is attributed to the increasing demand of blood components for transfusion from increasing surgical procedures and accidents & trauma cases, rapid development in the healthcare infrastructure, and increasing per capita income of the middle class population in the region.

Major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan), and Therakos, Inc. (U.S.).

About MarketsandMarkets:
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country India
Categories Medical , Research , Science
Tags apheresis , apheresis market , apheresis market research , apheresis market study , leukapheresis market , photopheresis market , plasmapheresis market , therapeutic market
Last Updated July 1, 2016